Advaxis to Present at the Aegis Annual Growth Conference
PRINCETON, N.J., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Robert Petit, Ph.D., executive vice president and chief scientific officer of …